NRXP

Nrx Pharmaceuticals Inc

• TipRanks·2d ago

  Psychedelic: AtaiBeckley reports publication of BPL-003 study results

• TipRanks·5d ago

  NRx Pharmaceuticals announces FDA labeling alignment for ketamine product

• Benzinga·5d ago

  NRx Pharmaceuticals Receives FDA Letter Regarding Comments On Minor Formatting Changes To Proposed Label For Its Preservative-Free Ketamine Product, The Company Expects To Submit Final Label In April

• Reuters·5d ago

  NRX PHARMACEUTICALS (NASDAQ:NRXP) ANNOUNCES FDA LABELING ALIGNMENT FOR NRX’S PRESERVATIVE-FREE KETAMINE APPLICATION

• TipRanks·04/02 13:55

  Psychedelic: Clearmind completes treatment, follow-up for CMND-100 trial

• Reuters·03/30 11:07

  NRx unit Hope Therapeutics partners with Emobot to deploy AI depression monitoring networkwide

• Reuters·03/30 11:00

  HOPE THERAPEUTICS, AN NRX PHARMACEUTICALS SUBSIDIARY (NASDAQ:NRXP), ANNOUNCES STRATEGIC PARTNERSHIP WITH EMOBOT TO INTEGRATE ITS AI-POWERED “DEPRESSION THERMOMETER” ACROSS ITS INTERVENTIONAL PSYCHIATRY NETWORK

• TipRanks·03/28 00:07

  Nrx Pharmaceuticals’ Earnings Call Signals High‑Stakes Progress

• TipRanks·03/26 15:00

  Psychedelic: Compass Pathways, NRx Pharma report earnings results

• TipRanks·03/25 10:11

  Analysts Are Bullish on Top Healthcare Stocks: NRX Pharmaceuticals (NRXP), Rezolute (RZLT)

• TipRanks·03/25 06:00

  Nrx Pharmaceuticals: Extensive Clinical, Regulatory, and Financial Risks Make Shares Highly Speculative

• TipRanks·03/24 21:05

  NRx Pharmaceuticals Stockholders Approve Incentive Plan Amendment

• Reuters·03/24 20:33

  NRX Pharmaceuticals held annual shareholder meeting, investors approved incentive plan amendment

• Dow Jones·03/24 18:59

  NRX Pharmaceuticals Price Target Maintained With a $34.00/Share by D. Boral Capital

• Dow Jones·03/24 18:59

  NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital